Alex Janin
Health Reporter at The Wall Street Journal
Health reporter with a sweet tooth. @WSJ covering longevity and preventive care
Articles
-
6 days ago |
wsj.com | Amy Dockser Marcus |Alex Janin
Join a real-time, written chat with Topol and WSJ’s health reporters on Tuesday, May 13, from 3-4 p.m. ET. WSJ subscribers can submit their questions at any time in the comments space below. The longevity business is booming. As people explore how to slow down or even reverse aging, longevity practices from supplements to IV drips to off-label drug use have become more common, boosted by health podcasters, fitness bros and some traditional doctors.
-
2 weeks ago |
wsj.com | Alex Janin
Runners, cyclists and other fitness enthusiasts say weight-loss drugs give them a performance edge, despite potential risksAmanda Rodriguez felt exceptionally proud as she ran the Chicago Marathon last fall. She also felt a touch weighed down. With other races on the horizon, she decided to go back on tirzepatide, the active ingredient in popular diabetes and weight-loss drugs Mounjaro and Zepbound. She had used it before to take off some excess weight.
-
3 weeks ago |
wsj.com | Alex Janin
A plant-rich diet with some fish and dairy might make the biggest difference, new research suggestsIf you reach 70 years old healthy and disease-free, you might have your diet to thank, new research suggests. The study, which analyzed the health data of more than 100,000 people over the course of 30 years, is the first of its kind to examine how dietary patterns affect not only lifespan but also how well people age.
-
1 month ago |
wsj.com | Alex Janin
Forget social clubs and extravagant dinners. The health-conscious elite are flocking to high-end clinics in the hopes of getting ahead of the aging process. Alex Janin | Photographs by Jonah Rosenberg for WSJ For up to six figures a year, longevity clinics promise to buy their patrons longer, healthier lives. For now, they’re conferring something maybe just as valuable: status. Plenty of people are deciding the hefty fees are worth it.
-
2 months ago |
tovima.com | Alex Janin
Research suggests benefits beyond what popular diabetes and weight-loss drugs were first approved to treatFor decades, scientists have been on the hunt for an antiaging drug. Now, some say we may have already found it. A fast-growing body of research signals potential health benefits of GLP-1s, the class of diabetes and weight-loss drugs known by names like Ozempic, beyond what they were initially approved to treat.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 10K
- Tweets
- 1K
- DMs Open
- Yes
RT @EricTopol: The @WSJ piece on SUPER AGERS, by @AmyDMarcus Gift link https://t.co/FrEzjgRcQ3 And please join us next Tuesday for a live…
TUESDAY: Join me, @AmyDMarcus and @EricTopol to answer readers' questions on the pursuit of living healthier for longer. Add your question here: https://t.co/wG3ZchHmV8 via @WSJ
RT @bykevinclark: My wife, Emily Glazer, just won the Pulitzer Prize. I’ve known this was going to happen since the day I met her. She is t…